STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #917 by analyst upside · 2026-09-09
VSTM
Verastem, Inc.
Healthcare · Market Cap $732M · P/E 0x
ANALYST PRICE TARGET
+85.6%
implied upside to consensus target
Current Price $8.08
Consensus Target $15.0
Bull Target $18.0
Bear Target $11.0
Analysts Covering 8
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
7
Hold
0
Sell
0
52-Week Low $3.43
52-Week High $10.82
YTD Return +11.8%
FUNDAMENTALS
Market Cap $732M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-2.44
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $88M
Profit Margin -231.6%
52-WEEK RANGE
52-Week Low $3.43
52-Week High $10.82
Current Price $8.08
Bear Target $11.0
Bull Target $18.0
● Now $8.08 ● Target $15.0
TRADING DATA
Avg Volume 2.4M
YTD Return +11.8%
Analyst Count 8
Consensus Buy
Upside to Target +85.6%
Last Updated 2026-09-09

ANALYST SUMMARY

Verastem, Inc. (VSTM) is currently trading at $8.08 with a Wall Street consensus price target of $15.0, implying potential upside of 85.6% over the next 12 months. 8 analysts currently cover VSTM, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $18.0, while the most cautious has a target of $11.0.

VSTM operates in the Healthcare sector with a market capitalisation of $732M. The stock is up 11.8% year-to-date and is currently trading near the upper end of its 52-week range of $3.43 – $10.82.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for VSTM, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Mizuho - Reiterated
Outperform → Outperform 2026-08-11 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-08-07 62% win rate (8 calls)
RBC Capital - Reiterated
Outperform → Outperform 2026-07-07 Building track record
BTIG - Reiterated
Buy → Buy 2026-07-02 38% win rate (8 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-06-24 31% win rate (48 calls)
BTIG reit
Buy → Buy 2026-06-24 38% win rate (8 calls)
Jefferies - Reiterated
Buy → Buy 2026-06-23 50% win rate (6 calls)
Mizuho - Reiterated
Outperform → Outperform 2026-05-14 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
57
out of 100
Coverage depth
17/30
Consensus clarity
13/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →